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Background: Septic shock is a common and often devastating syndrome marked by severe cardiovascular
dysfunction commonly managed with vasopressors. Whether markers of heart rate complexity before vasopressor
up-titration could be used to predict success of the up-titration is not known.
Methods: We studied patients with septic shock requiring vasopressor, newly admitted to the intensive care unit.
We measured the complexity of heart rate variability (using the ratio of fractal exponents from detrended
fluctuation analysis) in the 5 min before all vasopressor up-titrations in the first 24 h of an intensive care unit (ICU)
admission. A successful up-titration was defined as one that did not require further up-titration (or decrease in
mean arterial pressure) for 60 min.
Results: We studied 95 patients with septic shock, with a median APACHE II of 27 (IQR: 20–37). The median
number of up-titrations, normalized to 24 h, was 12.2 (IQR: 8–17) with a maximum of 49. Of the up-titrations, the
median proportion of successful interventions was 0.28 (IQR: 0.12–0.42). The median of mean arterial pressure (MAP)
at the time of a vasopressor up-titration was 66 mmHg; the average infusion rate of norepinephrine at the time of
an up-titration was 0.11 mcg/kg/min. The ratio of fractal exponents was not associated with successful up-titration
on univariate or multivariate regression. On exploratory secondary analyses, however, the long-term fractal
exponent was associated (p = 0.003) with success of up-titration. Independent of heart rate variability, MAP was
associated (p < 0.001) with success of vasopressor up-titration, while neither Sequential Organ Failure Assessment
(SOFA) nor Acute Physiology and Chronic Health Evaluation II (APACHE II) score was associated with vasopressor
titration.
Conclusions: Only a third of vasopressor up-titrations were successful among patients with septic shock. MAP and
the long-term fractal exponent were associated with success of up-titration. These two, complementary variables
may be important to the development of rational vasopressor titration protocols.
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Septic shock, the life-threatening manifestation of severe
infection, is associated with a near-term mortality of 20-
30 % [1–3]. Current consensus emphasizes early interven-
tion to control sepsis [4, 5], even if recent assumptions
about how best to do so have changed in the aftermath of
three large studies [6–8] that failed to demonstrate benefit
to the prior paradigm of “early goal-directed therapy,”
which had used multiple, integrated therapies to optimize
oxygen delivery [4]. While early antibiotics and source
control are nearly universally accepted, other details of
early sepsis management are not well understood.
Cardiovascular failure is common in sepsis, often result-
ing in multiple organ dysfunction syndrome (MODS),
which is frequently fatal. Vascular leakage causes a de-
crease in cardiac preload, and arterial dilation causes de-
crease in cardiac afterload. Microvascular dysfunction is
common, and cardiac function is often impaired [9, 10].
Together these phenomena contribute to a state of hypo-
perfusion that propagates septic MODS. Despite the lack
of clear physiological targets to track, current mainstays of
treatment for septic shock are volume expansion and
vasopressor administration, designed to increase cardiac
preload (and thereby cardiac output) and to raise the sys-
temic pressure for perfusion.
Vasopressors, primarily catecholamine hormones such
as norepinephrine, are generally administered in shock
to elevate the blood pressure (and recruit unstressed vol-
ume in capacitance veins to increase cardiac preload), in
order to assure perfusion of coronary arteries as well as
distal organs. While vasopressors are an important ther-
apy in patients with shock, it is unclear how best to ti-
trate them. While something like consensus supports
targeting a mean arterial pressure between 60–75 mmHg,
most clinicians adjust infusion rates by hand in hopes of
achieving whatever target is locally preferred [11].
Little work has been done to identify best methods of
vasopressor titration. Small studies have explored predic-
tors of the safety of vasopressor weaning in patients with
septic shock [12, 13] One possibility is that the degree of
dysfunction of the baroreflex system might be inform-
ative. An evolutionarily ancient system that maintains
cardiovascular homeostasis, the baroreflex is central to
the response to septic MODS. The baroreflex adjusts
vascular elastance, cardiac contractility, and heart rate.
The interval between heartbeats is determined by the
sinus node, which reflects the summary effects of mul-
tiple inputs into the baroreflex system. Analysis of the
changes in instantaneous heart rate over time, termed
“heart rate variability (HRV),” provides an important
window into autonomic control of the baroreflex system
in primary cardiac disease [14–16], acute trauma [17]
and sepsis [18, 19]. Notably, in health HRV exhibits non-
linear patterns of complexity, including characteristics ofchaotic systems. One key aspect of such chaotic systems
is that patterns are conserved across levels of scale, what
is called fractal self-similarity across time scales [20, 21].
Heart rate variability exhibits complex patterns that may
give insight into the interdependence of the autonomic
nervous system and inflammation in sepsis [22]. Com-
plexity analyses have been identified as a key research
priority in critical illness [23, 24]. Our prior work dem-
onstrated that loss of complexity in heart rate variability
is associated with worse outcomes in severe sepsis and
septic shock [25]. We therefore hypothesized that the
complexity of heart rate variability in the 5 min before
an increase in vasopressor infusion rates would be asso-
ciated with the success of that vasopressor increase.
Methods
Setting
We studied patients admitted to either of two ICUs, the
24-bed Shock Trauma ICU, and the 12-bed Respiratory
ICU, at Intermountain Medical Center, a 450-bed
tertiary-care, academic hospital in Murray, Utah, USA.
Typical clinical practice in the study ICUs is to titrate
vasopressors for a mean arterial pressure of 60-
65 mmHg.
Patients
We prospectively identified adult (>15 years of age) pa-
tients with septic shock (as defined in consensus guide-
lines [26]) admitted to study ICUs from June 2012 to
March 2015. We excluded pregnant patients, patients
with do-not-resuscitate/do-not-intubate (DNR/DNI) or-
ders at the time of ICU admission, and patients with
non-sinus rhythm. We only included patients the first
time they were admitted to a study ICU with sepsis dur-
ing the study period. Patients were only included at the
time of their initial admission to the ICU; we excluded
patients who developed sepsis after their admission to
the ICU.
We restricted the study to those patients who had at
least one increased infusion rate of vasopressors in the
first 24 h of their ICU admission for septic shock.
Clinical data
We calculated admission APACHE II [27] and SOFA [28]
scores in all study patients. Infusion rates of vasopressors
(norepinephrine, epinephrine, dopamine, phenylephrine,
and vasopressin) are automatically uploaded in real-time
to the hospital electronic medical record (EMR) as part of
routine clinical care. We analyzed all vasopressors admin-
istered during the first six hours after ICU admission, con-
verting them to norepinephrine equivalent dosages
according to standard equivalencies [29]. The EMR also
stores the values of heart rate and blood pressure at 30-s
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obtained from the Philips bedside monitors.
Physiological data acquisition and processing
Data were downloaded from Philips Intellivue Monitors
via the Research Data Export (RDE) functionality. RDE
provides 125-Hz digitized tracings of continuous electro-
cardiographic monitoring as well as identification of fi-
ducial points (the moment when the QRS complex
occurs). Using those fiducial points, we processed the
data within Continuous Individual Multiorgan VariabilityFig. 1 Depiction of detrended fluctuation analysisAnalysis (CIMVA) [30]. We used 5 min analytical win-
dows for CIMVA, incremented 2.5 min at each step. For
each vasopressor uptitration we used the complexity mea-
sures from the 5 min before the vasopressor uptitration
occurred. Our pre-specified primary predictors were en-
tropy and the ratio of exponents from detrended fluctu-
ation analysis, based on prior work [25, 31]. (We depict an
example detrended fluctuation analysis in Figure 1.)
Secondarily, we considered all CIMVA complexity mea-
sures as potential candidates. The CIMVA complexity
measures represent the range of validated complexity
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man physiological monitoring. These measures, or combi-
nations thereof, have been evaluated in a variety of acute
illness states [30–32]. CIMVA measures were not trans-
formed, combined, or otherwise modified in this study.
We considered secondary analyses to be exploratory and
hypothesis generating.
We only considered one vasopressor up-titration in
any five-minute period: if a vasopressor up-titration oc-
curred within 5 min after another, the latter up-titration
was used. Only up-titrations ≥ 0.01 mcg/kg/min were
considered. We excluded from consideration any up-
titration followed by a down-titration within 1.5 min.
Clinical outcomes
We defined, a priori, successful vasopressor up-titration
as maintenance of mean arterial pressure > 60 mm Hg
for 60 min after the increased dosage without further ti-
tration during those 60 min.
Statistical methods
Central tendencies and variance were expressed as mean
(standard deviation) or median (inter-quartile range) as
indicated by normality of the data. Statistical analysis
and hypothesis testing were performed within the R stat-
istical package version 3.1.3 [33], with OpenBUGS 3.2.3
used for Bayesian analyses. Generalized linear mixed
models (GLMM) were used to account for the depend-
ence structure within each patient, as multiple up-
titrations could occur per patient. A distinctive feature
of repeated measures is that they are clustered within
individuals. Observations within a cluster typically
exhibit positive correlation, the presence of which vio-
lates the crucial assumption of independence in standardFigure 2 Selection of patients for analysisstatistical models. The degree of clustering can be mea-
sured, and appropriate statistical models for clustered
data must account for the degree of clustering/non-inde-
pendence [34]. Generalized linear mixed models
(GLMM) can account for lack of independence within
clustered data by assigning each cluster of repeated mea-
sures its own intercept, the whole of which are con-
strained to be normally distributed. In this way, the
proportion of correlation due to clustering can be mea-
sured, allowing identification of reliable parameter esti-
mates [35]. We implemented univariate, multilevel
logistic regression with random intercepts, predicting
the probability of a vasopressor up-titration being suc-
cessful. Complexity measures were centered and scaled
to facilitate convergence of regression models. Using
bootstrapping to estimate power, we calculated that with
a sample size of 95, we had 80 % power with two-tailed
alpha = 0.05 to detect a 0.27 absolute difference in the
ratio of detrended fluctuation analysis (DFA) exponents
between successful and unsuccessful vasopressor up-
titrations.
Results
Of 117 patients with septic shock requiring vasopressor
infusions, 95 (81 %) had adequate arterial blood pressure
data and interpretable HRV complexity data. Figure 2
depicts the flow of patients through screening and ana-
lysis. Table 1 depicts patient demographics, measures of
disease severity, and sources of sepsis. Patients had a
median APACHE II score of 27 (20–37). Patients re-
ceived vasopressors for median 23 h (20–24), with four
individuals receiving vasopressors for 500 h or more.
A total of 964 up-titrations among the 95 patients
were analyzed. The median number of up-titrations per
Table 1 Descriptive statistics
Median (IQI)
Age (years) 59.0 (47.5 to
66.5)
SOFA 11 (8 to 13)
APACHE II 27 (20 to
36.5)
Mean heart rate (bpm) 103 (93 to 119)
MAP at up-titration (mmHg) 66 (61 to 72)




Number of interventions (normalized to 24 h) 12.2 (8.0 to
17.2)
Number of successful interventions (normalized
to 24 h)
3.0 (1.3 to 4.8)




Duration of NEE administration (hours) 22.8 (19.9 to
23.6)
Proportion (n)
Female 52.6 % (50)
MAP≤ 65 at interventions (mmHg) 49.0 % (472)
MAP≤ 60 at interventions (mmHg) 23.0 % (222)
Source of sepsis
Pneumonia 32.6 % (31)
Abdominal 29.5 % (28)
Soft tissue 16.8 % (16)
Urinary 10.5 % (10)
Uncertain 3.2 % (3)
Bacteremia 2.1 % (2)
Joint 2.1 % (2)
Endocarditis 1.1 % (1)
Line infection 1.1 % (1)
Other 1.1 % (1)
Table 2 Results of primary regression analyses for fractal
exponents
Variable OR 95 % CI p
Ratio of exponents 1.055 0.890 –1.25 0.54
MAP 1.3 1.09 –1.56 0.004
Delta NEE 1.3 0.9 –1.89 0.163
Age 0.96 0.75 –1.23 0.741
Male 0.77 0.46 –1.29 0.323
SOFA 1.04 0.93 –1.17 0.476
APACHE II 0.97 0.94 –1.01 0.133
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maximum of 49. Of the up-titrations, the median propor-
tion of successful interventions was 0.28 (IQR: 0.12–0.42).
In four patients with at least two up-titrations, 100 % of
up-titrations were successful. The median of the mean
arterial pressure (MAP) at the time of a vasopressor up-
titration was 66 mmHg; the average infusion rate of
norepinephrine at the time of an up-titration was 0.11
mcg/kg/min.
Primary analysis
For our pre-specified primary analysis, we evaluated the
ratio of fractal scaling coefficients from detrended fluc-
tuation analysis and Sample Entropy. Neither was associ-
ated with successful up-titration on univariate analysis
or on bivariate analysis controlling for MAP at the timeof up-titration. When controlling for age, sex, and ad-
mission APACHE II, there was also no significant associ-
ation. The results for the model evaluating the ratio of
scaling coefficients is displayed in Table 2, while the re-
sults for the model including sample entropy are dis-
played in Table 3.
Exploratory secondary analyses
In prespecified exploratory analyses, we evaluated the
association of all CIMVA complexity measures against
the primary outcome. Notably, the overall fractal expo-
nent (p = 0.003) and the long-term fractal exponent (p =
0.003) were significantly associated with success of vaso-
pressor titration, effects which persisted after control for
APACHE II, MAP, age and sex (p = 0.007 for both). We
display these findings in Table 4. Additional file 1: Table
S1, in the online data supplement, displays the candidate
predictors with odds ratios and p values for univariate
and multivariate associations.
The distributions of the long-term fractal exponent
differed between up-titrations that were successful
(n = 229, median 1.11, IQR 0.926 to 1.32) and those
that were unsuccessful (n = 735, median 1.05, IQR 0.739
to 1.25) (p < 0.001). The distributions of the overall fractal
exponent also differed between up-titrations that were
successful (median 1.02, IQR 0.800 to 1.28) and those that
were unsuccessful (median 0.956, IQR 0.597 to 1.20) (Wil-
coxon rank sum test p < 0.001).
In an exploratory analysis of other clinical predictors
of successful vasopressor up-titration, MAP before the
up-titration was strongly associated (p < 0.001) with suc-
cess of the up-titration; trends toward association be-
tween the size of the up-titration (p = 0.09) and
APACHE II score (p = 0.08) and success of up-titration
were also observed. None of age, sex, and SOFA score
was associated with success of vasopressor up-titration.
Discussion
In this prospective study of patients admitted to the ICU
with septic shock, an array of heart rate complexity mea-
sures were not significantly associated with the success of
Table 3 Results of primary regression analysis for sample
entropy
Variable OR 95 % CI p
Sample entropy 0.97 0.81 –1.16 0.76
MAP 1.3 1.08 –1.55 0.005
Delta NEE 1.29 0.89 –1.86 0.177
Age 0.95 0.74 –1.22 0.708
Male 0.78 0.46 –1.31 0.341
SOFA 1.04 0.93 –1.17 0.468
APACHE II 0.97 0.93 –1.01 0.117
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comparisons. While we had hypothesized, on the basis of
prior work on early sepsis resuscitation [25], that the ratio
of fractal scaling coefficients would be associated with out-
come, the overall and long-term coefficients, rather than
the ratio or the short-term coefficient, appeared promising
on an exploratory analysis.
The long-term and overall fractal exponents were sug-
gestive on exploratory analysis, even after control for se-
verity of illness. A higher exponent was associated with
a higher probability of success. This higher exponent
represents an increase in variability (“fluctuation”) over
time intervals longer than approximately one minute
(i.e., around 100 heart beats), with greater variability
over longer time intervals. It may be that patients in
whom that variability is lower are less likely to respond
to vasopressor up-titrations because they have more
severe vasoplegia or, contrarily, have a defect in cardiac
rather than vascular function. Recent work on the
mismatch between ventricular and arterial elastance
(“ventriculo-arterial decoupling”) in septic shock sug-
gests that certain patients may differentially benefit from
vasoconstriction versus fluid loading or inotropic sup-
port. [36] It is possible that in our cohort some vaso-
pressor up-titrations were unsuccessful because of
ventriculo-arterial decoupling. Future work should ex-
plore possible relationships between detrended fluctu-
ation analysis and ventriculo-arterial decoupling. In our
prior work, higher long-term fractal exponents at the
time of ICU admission were associated with a lower
probability of vasopressor independence at 24 h [25].
Our current observations also suggest that the temporal
arc of septic shock may be relevant to the success ofTable 4 Results of exploratory regression analyses for additional resu
Univariate
Variable OR (95 % CI) p value
Long-term fractal exponent 1.3 (1.1–1.6) 0.003
Overall fractal exponent 1.4 (1.1–1.7) 0.003
aThe bivariate model controlled for mean arterial pressure (MAP)
bThe multivariate model controlled for MAP, magnitude of vasopressor up-titration,vasopressor up-titrations in the short term versus liber-
ation from vasopressor therapy over the intermediate
term. The precise nature of this association is worth ex-
ploring if future work validates these current observations.
Beyond evaluation of specific predictors, our study pro-
vides a useful snapshot of current vasopressor titration
practices. On average, doses are adjusted approximately a
dozen times in a 24-h period. While the nominal practice
in the study ICUs is to target 65 mmHg, many adjust-
ments are made at a moment when the MAP is slightly
higher, perhaps representing a desire to never fall below
the target MAP. Our study also documents the reality
that only about a third of vasopressor up-titrations
were successful. This raises the possibility that im-
proved predictive models could facilitate higher-
quality approaches to the titration of vasopressors.
On the basis of our data, the MAP at the time of
up-titration should be incorporated into such pre-
dictive models. It may be that the MAP is the most
important predictor, and heart rate variability metrics
may contribute relatively little. In many if not most
control systems, the distance between the current
and desired level of a parameter of interest is a key
determinant of the required input. Future work
should address whether the distance between desired
and current blood pressure could guide vasopressor
titration.
Early work in dogs has suggested the possibility that
automated control of vasopressor infusions may be pos-
sible [37]. To our knowledge, this work has not been
replicated in humans. Merouani and colleagues success-
fully used fuzzy logic for a vasopressor weaning protocol.
[13] In uncontrolled work, the dynamic arterial elastance
(a measure of vasodilation) of patients in septic shock
predicted that the patients were ready for weaning from
norepinephrine [12].
With ongoing interest in understanding optimal MAP
goals [38], our results suggest the importance of more
explicit protocols given how often an up-titration is not
effective and how often up-titrations occur when the
MAP is higher than the target.
Prior work has suggested that complexity metrics may be
useful for clinical management of patients with or at risk
for infection. Among premature infants, a complexity-
monitoring system focused on entropy measurements
demonstrated improved outcomes, primarily as an earlylts from detrended fluctuation analysis
Bivariatea Multivariateb
OR (95 % CI) p value OR (95 % CI) p value
1.3 (1.1–1.6) 0.005 1.3 (1.1–1.6) 0.007
1.3 (1.1–1.6) 0.005 1.3 (1.1–1.6) 0.007
APACHE II, SOFA, age, and sex
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ity measure was associated with greater probability of extu-
bation success in a multi-center study [32].
A strength of this study is our prespecified analytic ap-
proach, including primary predictors and clinical out-
comes. Our use of prespecified primary analyses decreases
the chance of Type 1 statistical error. Our non-definitive,
exploratory analyses suggest that it would be reasonable
to evaluate the overall and long-term fractal exponents in
another cohort to ensure that the null hypothesis has not
been accepted incorrectly.
Limitations of this study include the fact that in study
ICUs vasopressor titration is predominantly performed
by the bedside nurse, at her/his discretion. This practice
likely results in unmeasured inter- and intra-clinician
variation, which we were unable to control for.
Conclusions
In summary, the long-term fractal exponent of heart rate
variability and mean arterial pressure at the time of a
vasopressor up-titration may be predictive of the success
of that vasopressor up-titration. Further work is indi-
cated to improve the rationality and predictability of
vasopressor titration for patients with septic shock.
Additional file
Additional file 1: Table S1. Online Data Supplement. Evaluated
complexity measures and association with success of vasopressor titration
on univariate and multivariate analyses. (DOCX 30 kb)
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